首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Prophylactic effect of Malarone against malaria: all good news?
被引:13
作者
:
Nosten, F
论文数:
0
引用数:
0
h-index:
0
机构:
Shoklo Malaria Res Unit, Mae Sot, Thailand
Nosten, F
机构
:
[1]
Shoklo Malaria Res Unit, Mae Sot, Thailand
[2]
Mahidol Univ, Fac Trop Med, Bangkok, Thailand
[3]
John Radcliffe Hosp, Dept Clin Med, Oxford OX3 9DU, England
来源
:
LANCET
|
2000年
/ 356卷
/ 9245期
关键词
:
D O I
:
10.1016/S0140-6736(00)03250-5
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:1864 / 1865
页数:2
相关论文
共 13 条
[11]
A mechanism for the synergistic antimalarial action of atovaquone and proguanil
[J].
Srivastava, IK
论文数:
0
引用数:
0
h-index:
0
机构:
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Srivastava, IK
;
Vaidya, AB
论文数:
0
引用数:
0
h-index:
0
机构:
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Vaidya, AB
.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1999,
43
(06)
:1334
-1339
[12]
A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone® (atovaquone/proguanil) for the prophylaxis of malaria in Zambia
[J].
Sukwa, TY
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Sukwa, TY
;
Mulenga, M
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Mulenga, M
;
Chisdaka, N
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Chisdaka, N
;
Roskell, NS
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Roskell, NS
;
Scott, TR
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Scott, TR
.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE,
1999,
60
(04)
:521
-525
[13]
White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301
←
1
2
→
共 13 条
[11]
A mechanism for the synergistic antimalarial action of atovaquone and proguanil
[J].
Srivastava, IK
论文数:
0
引用数:
0
h-index:
0
机构:
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Srivastava, IK
;
Vaidya, AB
论文数:
0
引用数:
0
h-index:
0
机构:
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Med Coll Penn & Hahnemann Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA
Vaidya, AB
.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1999,
43
(06)
:1334
-1339
[12]
A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone® (atovaquone/proguanil) for the prophylaxis of malaria in Zambia
[J].
Sukwa, TY
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Sukwa, TY
;
Mulenga, M
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Mulenga, M
;
Chisdaka, N
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Chisdaka, N
;
Roskell, NS
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Roskell, NS
;
Scott, TR
论文数:
0
引用数:
0
h-index:
0
机构:
Glaxo Wellcome Inc, HIV & Opportunist Infect Clin Dev, Res Triangle Pk, NC 27709 USA
Scott, TR
.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE,
1999,
60
(04)
:521
-525
[13]
White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301
←
1
2
→